Cargando…

SARS-CoV-2 Infection: Differences in Hematological Parameters Between Adults and Children

Since December 2019, corona virus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has become a global pandemic, posing a huge threat to human health, and the current epidemic prevention situation is still severe. Hematological parameters directly reflec...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Lanqin, She, Jiatong, Bai, Yongqi, Liu, Wenjun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8254608/ https://www.ncbi.nlm.nih.gov/pubmed/34234532 http://dx.doi.org/10.2147/IJGM.S313860

Ejemplares similares

Genetic Examination of Hematological Parameters in SARS-CoV-2 Infection and COVID-19
por: Rowland, Bryce, et al.
Publicado: (2022)

Associations between hematological parameters and disease severity in patients with SARS‐CoV‐2 infection
por: Lin, Sha, et al.
Publicado: (2020)

Adherence to Sars-CoV2 vaccination in hematological patients
por: Narinx, Justine, et al.
Publicado: (2022)

Measures for preventing nosocomial infection with SARS-CoV-2 in hematology departments
por: Wang, Yingying, et al.
Publicado: (2020)

Pathological Effects of SARS-CoV-2 Associated with Hematological Abnormalities
por: Shama, et al.
Publicado: (2023)

Evaluation of the Diagnostic Value of Hematologic Parameters and Ratios in SARS-CoV-2 VOC-202012/01 Mutant Population
por: Seyit, Murat, et al.
Publicado: (2022)

Patient hematology during hospitalization for viral pneumonia caused by SARS-CoV-2 and non-SARS-CoV-2 agents: a retrospective study
por: Bai, Bingke, et al.
Publicado: (2021)

Human Coronaviruses SARS-CoV, MERS-CoV, and SARS-CoV-2 in Children
por: Aleebrahim-Dehkordi, Elahe, et al.
Publicado: (2021)

Clinical efficacy analysis of paxlovid in children with hematological diseases infected with the omicron SARS-CoV-2 new variant
por: Li, Yixian, et al.
Publicado: (2023)

A Diagnostic Model to Predict SARS-CoV-2 Positivity in Emergency Department Using Routine Admission Hematological Parameters
por: Soloperto, Rossana, et al.
Publicado: (2021)

Weak immunogenicity of SARS-CoV-2 vaccine in patients with hematologic malignancies
por: Malard, Florent, et al.
Publicado: (2021)

Hematological Changes in the Second Wave of SARS-CoV-2 in North India
por: Singh, Akanksha, et al.
Publicado: (2022)

Antibody response to SARS-CoV-2 vaccines in patients with hematologic malignancies
por: Greenberger, Lee M., et al.
Publicado: (2021)

Seroconversion to mRNA SARS-CoV-2 Vaccines in Hematologic Patients
por: Fattizzo, Bruno, et al.
Publicado: (2022)

Beyond SARS-CoV2, the role of viruses in the pathogenesis of hematologic malignancies
por: Wiestner, Adrian
Publicado: (2022)

Characterization of post-vaccination SARS-CoV-2 T cell subtypes in patients with different hematologic malignancies and treatments
por: Pfannes, Roald, et al.
Publicado: (2023)

SARS-CoV-2 Infection in Children
por: Lu, Xiaoxia, et al.
Publicado: (2020)

462. Differences in the Humoral Response to SARS-CoV-2 Infection in Children vs. Adult
por: Mentor, Girlande, et al.
Publicado: (2021)

Characteristics of SARS-CoV-2 Infections in Israeli Children During the Circulation of Different SARS-CoV-2 Variants
por: Somekh, Ido, et al.
Publicado: (2021)

Evaluation of hematological parameters and thrombocytopenia following Pfizer-BioNTech (BNT162b2) SARS-CoV-2 vaccination
por: Algaissi, Abdullah, et al.
Publicado: (2022)

Persistence of SARS-CoV-2 virus RNA in feces: A case series of children
por: Du, Wenjun, et al.
Publicado: (2020)

SARS CoV 2 infection in chronic myelogenous leukemia: Severe hematological presentation
por: Sorà, Federica, et al.
Publicado: (2020)

Therapy in Patients with Hematologic Malignancies, Seroconversion Rates, and SARS-CoV-2 Vaccination
por: Sriwijitalai, Won, et al.
Publicado: (2022)

Children and SARS-CoV-2
por: Bogunovic, Dusan, et al.
Publicado: (2021)

Hematological findings in adult patients with SARS CoV‐2 infection at Tygerberg Hospital Cape Town South Africa
por: Abdullah, Ibtisam, et al.
Publicado: (2022)

Similarities and Differences of Early Pulmonary CT Features of Pneumonia Caused by SARS-CoV-2, SARS-CoV and MERS-CoV: Comparison Based on a Systemic Review
por: Chen, Xu, et al.
Publicado: (2020)

Differences in Clinical Features and Laboratory Results between Adults and Children with SARS-CoV-2 Infection
por: Li, Xiaoli, et al.
Publicado: (2020)

The Cross-Protective Immunity Landscape Among Different SARS-CoV-2 Variant RBDs
por: Sun, Wenqiang, et al.
Publicado: (2022)

Implications of SARS-CoV-2 infection on the clinical, hematological, and inflammatory parameters in COVID-19 patients: A retrospective cross-sectional study
por: Damiati, Laila A., et al.
Publicado: (2022)

SARS-CoV-2 Altered Hemorheological and Hematological Parameters during One-Month Observation Period in Critically Ill COVID-19 Patients
por: Bizjak, Daniel Alexander, et al.
Publicado: (2022)

Sensitivity of SARS‐CoV‐2 to different temperatures
por: Lv, Qi, et al.
Publicado: (2020)

Comparative susceptibility of SARS-CoV-2, SARS-CoV, and MERS-CoV across mammals
por: Li, Meng, et al.
Publicado: (2023)

Inhalable nanocatchers for SARS-CoV-2 inhibition
por: Zhang, Han, et al.
Publicado: (2021)

Impact of Sars-CoV2 Infection on 491 Hematological Patients: The Ecovidehe Multicenter Study
por: De Ramón, Cristina, et al.
Publicado: (2020)

SARS-CoV-2 vaccine response and rate of breakthrough infection in patients with hematological disorders
por: Piñana, José Luis, et al.
Publicado: (2022)

Autoimmune- and complement-mediated hematologic condition recrudescence following SARS-CoV-2 vaccination
por: Portuguese, Andrew Jay, et al.
Publicado: (2021)

Immune biomarkers to predict SARS-CoV-2 vaccine effectiveness in patients with hematological malignancies
por: Tamariz-Amador, Luis-Esteban, et al.
Publicado: (2021)

SARS-CoV-2 vaccine-induced humoral and cellular immunity in patients with hematologic malignancies
por: Haggenburg, Sabine, et al.
Publicado: (2022)

Clinical and immunological characteristics of prolonged SARS-CoV-2 Omicron infection in hematologic disease
por: Ikeda, Daisuke, et al.
Publicado: (2023)

SARS-CoV-2 infection in children
por: Çokuğraş, Haluk, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_34hc3hec8lgapb72atarqe40g8